List of Contents

Dental Extraction Forceps Market Size, Share, and Trends 2024 to 2033

Dental Extraction Forceps Market (By Product Type: Upper Extracting Forceps, Lower Extraction Forceps, Others; By Therapeutics: Restorative Dentistry, Cosmetic Dentistry, Orthodontics Dentistry, Endodontics Dentistry; By End-user: Adults, Children, Animals) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : April 2024
  • Report Code : 4131
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Dental Extraction Forceps Market 

5.1. COVID-19 Landscape: Dental Extraction Forceps Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Dental Extraction Forceps Market, By Product Type

8.1. Dental Extraction Forceps Market Revenue and Volume, by Product Type, 2024-2033

8.1.1 Upper Extracting Forceps

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Lower Extraction Forceps

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Others

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Dental Extraction Forceps Market, By Therapeutics

9.1. Dental Extraction Forceps Market Revenue and Volume, by Therapeutics, 2024-2033

9.1.1. Restorative Dentistry

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Cosmetic Dentistry

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Orthodontics Dentistry

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Endodontics Dentistry

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Dental Extraction Forceps Market, By End-user 

10.1. Dental Extraction Forceps Market Revenue and Volume, by End-user, 2024-2033

10.1.1. Adults

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Children

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Animals

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Dental Extraction Forceps Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Therapeutics (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2033)

Chapter 12. Company Profiles

12.1. ASA DENTAL

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. J&J Instruments

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Karl Schumacher

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Kohler Medizintechnik

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LASCOD

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. MEDESY

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Carl Martin

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. FASA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Helmut Zepf Medizintechnik

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Hu-Friedy

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us